132 related articles for article (PubMed ID: 15467753)
1. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.
Dai JL; Wang L; Sahin AA; Broemeling LD; Schutte M; Pan Y
Oncogene; 2004 Nov; 23(53):8681-7. PubMed ID: 15467753
[TBL] [Abstract][Full Text] [Related]
2. Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation.
Voltz JW; Weinman EJ; Shenolikar S
Oncogene; 2001 Oct; 20(44):6309-14. PubMed ID: 11607833
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
4. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
Pan Y; Wang L; Dai JL
Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
[TBL] [Abstract][Full Text] [Related]
5. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
6. The epithelial brush border Na+/H+ exchanger NHE3 associates with the actin cytoskeleton by binding to ezrin directly and via PDZ domain-containing Na+/H+ exchanger regulatory factor (NHERF) proteins.
Cha B; Donowitz M
Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):863-71. PubMed ID: 18430067
[TBL] [Abstract][Full Text] [Related]
7. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
Dejmek J; Leandersson K; Manjer J; Bjartell A; Emdin SO; Vogel WF; Landberg G; Andersson T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):520-8. PubMed ID: 15701836
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
Yuan Y; Mendez R; Sahin A; Dai JL
Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
[TBL] [Abstract][Full Text] [Related]
9. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
10. A C-terminal PDZ motif in NHE3 binds NHERF-1 and enhances cAMP inhibition of sodium-hydrogen exchange.
Weinman EJ; Wang Y; Wang F; Greer C; Steplock D; Shenolikar S
Biochemistry; 2003 Nov; 42(43):12662-8. PubMed ID: 14580213
[TBL] [Abstract][Full Text] [Related]
11. Na+-H+ exchanger regulatory factor 1 (NHERF1) PDZ scaffold binds an internal binding site in the scavenger receptor megalin.
Slattery C; Jenkin KA; Lee A; Simcocks AC; McAinch AJ; Poronnik P; Hryciw DH
Cell Physiol Biochem; 2011; 27(2):171-8. PubMed ID: 21325834
[TBL] [Abstract][Full Text] [Related]
12. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins.
Hall RA; Ostedgaard LS; Premont RT; Blitzer JT; Rahman N; Welsh MJ; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8496-501. PubMed ID: 9671706
[TBL] [Abstract][Full Text] [Related]
13. The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface.
Lazar CS; Cresson CM; Lauffenburger DA; Gill GN
Mol Biol Cell; 2004 Dec; 15(12):5470-80. PubMed ID: 15469991
[TBL] [Abstract][Full Text] [Related]
14. A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration.
James MF; Beauchamp RL; Manchanda N; Kazlauskas A; Ramesh V
J Cell Sci; 2004 Jun; 117(Pt 14):2951-61. PubMed ID: 15161943
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
Yuan Y; Liu H; Sahin A; Dai JL
Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
[TBL] [Abstract][Full Text] [Related]
17. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
Wang L; Devarajan E; He J; Reddy SP; Dai JL
Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
[TBL] [Abstract][Full Text] [Related]
18. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange.
Hall RA; Premont RT; Chow CW; Blitzer JT; Pitcher JA; Claing A; Stoffel RH; Barak LS; Shenolikar S; Weinman EJ; Grinstein S; Lefkowitz RJ
Nature; 1998 Apr; 392(6676):626-30. PubMed ID: 9560162
[TBL] [Abstract][Full Text] [Related]
19. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
[TBL] [Abstract][Full Text] [Related]
20. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
